|
|
Volumn 18, Issue 5, 2002, Pages 297-301
|
|
The lidocaine patch 5% effectively treats all neuropathic pain qualities: Results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale
a
|
|
Author keywords
Neuropathic pain; Neuropathic Pain Scale; Pain mechanism; Pain treatment; Postherpetic neuralgia; Topical lidocaine
|
|
Indexed keywords
LIDOCAINE;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PAIN;
PAIN ASSESSMENT;
PATHOPHYSIOLOGY;
POSTHERPETIC NEURALGIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADULT;
ANALYSIS OF VARIANCE;
ANESTHETICS, LOCAL;
DELAYED-ACTION PREPARATIONS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HERPES ZOSTER;
HUMANS;
LIDOCAINE;
MALE;
NEURALGIA;
PAIN MEASUREMENT;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
VEHICLES;
|
|
EID: 0036041665
PISSN: 07498047
EISSN: None
Source Type: Journal
DOI: 10.1097/00002508-200209000-00004 Document Type: Article |
|
Times cited : (234)
|
|
References (8)
|
